Product NDC: | 10019-176 |
Proprietary Name: | Morphine Sulfate |
Non Proprietary Name: | Morphine Sulfate |
Active Ingredient(s): | 5 mg/mL & nbsp; Morphine Sulfate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10019-176 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20100526 |
Package NDC: | 10019-176-44 |
Package Description: | 25 VIAL in 1 BOX (10019-176-44) > 1 mL in 1 VIAL (10019-176-39) |
NDC Code | 10019-176-44 |
Proprietary Name | Morphine Sulfate |
Package Description | 25 VIAL in 1 BOX (10019-176-44) > 1 mL in 1 VIAL (10019-176-39) |
Product NDC | 10019-176 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Morphine Sulfate |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20100526 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | MORPHINE SULFATE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |